" It is imperative that the Company generate unass
Post# of 148110
Well alright then & Dr. J has been @ Cytodyn much longer than the avg shareholder realizes.
Taken as closed issue on which path for adding value to the patents.
So expecting no more shuffling & we're off to the races.
Wow what a journey.
Shall see....